Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2026, Vol. 31 ›› Issue (3): 313-323.doi: 10.12092/j.issn.1009-2501.2026.03.003
Previous Articles Next Articles
Xiaomian LIU1(
), Ying LIU1, Wenjing TU1, Shuo ZHANG1, Gaoyan ZHU1, Yuyan CUI1, Xiaoyu CUI1, Yixuan YANG1, Xiaobing LI2,*(
), Hongtao GUO3, Dong LI4, Xiaojuan HE5
Received:2025-05-09
Revised:2025-08-28
Online:2026-03-26
Published:2026-04-03
Contact:
Xiaobing LI
E-mail:lxmianjyjy@163.com;baishaoyao@163.com
CLC Number:
Xiaomian LIU, Ying LIU, Wenjing TU, Shuo ZHANG, Gaoyan ZHU, Yuyan CUI, Xiaoyu CUI, Yixuan YANG, Xiaobing LI, Hongtao GUO, Dong LI, Xiaojuan HE. Unraveling the molecular mechanisms of modified Er-Miao-San (MEMS) in acute gouty arthritis: a multidisciplinary integration of network pharmacology, molecular docking, and experimental validation[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(3): 313-323.
Fig.3 The TCM-active components-drug targets network Rectangles represent the intersection targets of drugs and diseases, triangles represent the core active components of drugs, rhombuses represent the categories of traditional Chinese medicine, and concave quadrilaterals represent the common active components of drugs.
| Number | Molecule ID | Molecule name | OB(%) | DL | TCM | Degree |
| 1 | MOL000098 | Quercetin | 46.43 | 0.28 | HuangBai, TuFuLing | 51 |
| 2 | MOL000358 | beta-sitosterol | 36.91 | 0.75 | HuangBai, TuFuLing, ShanCiGu | 37 |
| 3 | MOL000173 | wogonin | 30.68 | 0.23 | CangZhu | 29 |
| 4 | MOL000449 | Stigmasterol | 43.83 | 0.76 | HuangBai, TuFuLing, ShanCiGu | 29 |
Table 1 Core active compounds of MEMS and their degree values
| Number | Molecule ID | Molecule name | OB(%) | DL | TCM | Degree |
| 1 | MOL000098 | Quercetin | 46.43 | 0.28 | HuangBai, TuFuLing | 51 |
| 2 | MOL000358 | beta-sitosterol | 36.91 | 0.75 | HuangBai, TuFuLing, ShanCiGu | 37 |
| 3 | MOL000173 | wogonin | 30.68 | 0.23 | CangZhu | 29 |
| 4 | MOL000449 | Stigmasterol | 43.83 | 0.76 | HuangBai, TuFuLing, ShanCiGu | 29 |
Fig.8 Conformational stability analysis of TNF in complex with β-sitosterol or stigmasterol A-C: RMSD, RMSF, and Rg profiles of the TNF-β-sitosterol complex; D-F: corresponding profiles of the TNF-stigmasterol complex.
Fig.9 Hydrogen bonding and binding free energy analysis A,B: number of hydrogen bonds in the TNF-β-sitosterol and TNF-stigmasterol complexes, respectively. C,D: binding free energy decomposition. E,F: per-residue energy contributions for each complex.
Fig.11 Effects of MEMS on ankle joint swelling, toe volume swelling, gait score, and inflammatory index in AGA rats A: ankle swelling before and 12 h after MSU injection; B: comparison of the degree of right posterior ankle joint swelling, the degree of toe volume ankle swelling, gait assessment score and Inflammatory index in rats of different group ($ \overline{x} $±s, n=6). bP<0.05, cP<0.01, compared with model group; eP<0.05, compared with EMS group.
Fig.12 Results of various indexes in rats ($ \overline{x} $±s, n=6) A: TNF-α; B: IL-1β; C: IL-6; D: IL-17; E: SOD; F: GSH; G: MDA. bP<0.05, cP<0.01, compared with control group; eP<0.05, fP<0.01, compared with Model group; hP<0.05, compared with EMS group.
Fig.13 HE staining of synovial tissues in rat ankle joints across experimental groups ($ \overline{x} $±s, n=6) The representative image of HE staining in synovial tissue (Scale bar=100 μm); the histological quantitative score of synovial tissue sections was average±SD. cP<0.01, compared with control group; eP<0.05, fP<0.01, compared with model group.
Fig.14 The expression levels of NLRP3 and STAT3 protein in ankle joint tissue of rats ($ \overline{x} $±s, n=6) A: STAT3 protein expression; B: NLRP3 protein expression; C: electrophoresis of STAT3 and NLRP3 proteins. cP<0.01, compared with control group; fP<0.01, compared with model group; iP<0.01, compared with EMS group.
| 1 |
Patil T, Soni A, Acharya S. A brief review on in vivo models for Gouty Arthritis[J]. Metab Open, 2021, 11, 100100.
doi: 10.1016/j.metop.2021.100100 |
| 2 |
Cross M, Ong KL, Culbreth GT, et al. Global, regional, and national burden of gout, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021[J]. Lancet Rheumatol, 2024, 6 (8): e507- e517.
doi: 10.1016/S2665-9913(24)00117-6 |
| 3 |
Guo B, Zhao CP, Zhang C, et al. Elucidation of the anti-inflammatory mechanism of Er Miao San by integrative approach of network pharmacology and experimental verification[J]. Pharmacol Res, 2022, 175, 106000.
doi: 10.1016/j.phrs.2021.106000 |
| 4 | Chen G, Li KK, Fung CH, et al. Er-Miao-San, a traditional herbal formula containing Rhizoma Atractylodis and Cortex Phellodendri inhibits inflammatory mediators in LPS-stimulated RAW264. 7 macrophages through inhibition of NF-κB pathway and MAPKs activation [J]. J Ethnopharmacol, 2014, 154(3): 711-718. |
| 5 |
梁浩瀚, 崔伟, 叶来生, 等. 土茯苓及其活性成分防治痛风性关节炎作用与机制研究进展[J]. 中药材, 2023, 46 (10): 2628- 2639.
doi: 10.13863/j.issn1001-4454.2023.10.042 |
| 6 |
陈诗, 赵玥, 王振, 等. 山慈菇药理作用及临床应用研究进展[J]. 中华中医药学刊, 2023, 41 (6): 247- 250.
doi: 10.13193/j.issn.1673-7717.2023.06.054 |
| 7 |
袁莉莉, 王倩. 基于网络药理学研究泽泻汤治疗脑水肿的作用机制[J]. 长春中医药大学学报, 2019, 35 (5): 912- 915.
doi: 10.13463/j.cnki.cczyy.2019.05.028 |
| 8 |
王芳, 李峰. 基于网络药理学研究二妙方治疗新型冠状病毒肺炎的潜在作用机制[J]. 现代中药研究与实践, 2022, 36 (3): 43- 48.
doi: 10.13728/j.1673-6427.2022.03.009 |
| 9 |
Coderre TJ, Wall PD. Ankle joint urate arthritis (AJUA) in rats: an alternative animal model of arthritis to that produced by Freund's adjuvant[J]. Pain, 1987, 28 (3): 379- 393.
doi: 10.1016/0304-3959(87)90072-8 |
| 10 |
Li H, Zhang X, Gu L, et al. Anti-gout effects of the medicinal fungus phellinus igniarius in hyperuricaemia and acute gouty arthritis rat models[J]. Front Pharmacol, 2022, 12, 801910.
doi: 10.3389/fphar.2021.801910 |
| 11 |
肖敬, 尹智功, 蒋耀平, 等. 青藤碱对痛风性关节炎模型大鼠IL-6的影响[J]. 河南中医, 2018, 38 (4): 536- 539.
doi: 10.16367/j.issn.1003-5028.2018.04.0143 |
| 12 |
陈海娟, 高禹涵, 徐丽, 等. 十味乳香胶囊对类风湿性关节炎大鼠的治疗作用[J]. 华西药学杂志, 2024, 39 (3): 274- 278.
doi: 10.13375/j.cnki.wcjps.2024.03.007 |
| 13 |
王赓丰, 马俊福, 邓雍钲, 等. 基于NF-κB通路探讨痛风汤对急性痛风性关节炎模型大鼠炎症的影响机制[J]. 陕西中医, 2024, 45 (6): 740- 744.
doi: 10.3969/j.issn.1000-7369.2024.06.004 |
| 14 |
王海坤, 苏丹, 吴娜, 等. 基于网络药理学和分子对接探讨上中下通用痛风方治疗痛风性关节炎的分子机制[J]. 特产研究, 2023, 45 (2): 66- 73+80.
doi: 10.16720/j.cnki.tcyj.2023.043 |
| 15 |
de Sá Müller CM, Coelho GB, Araújo MCPM, et al. Lychnophora pinaster ethanolic extract and its chemical constituents ameliorate hyperuricemia and related inflammation[J]. J Ethnopharmacol, 2019, 242, 112040.
doi: 10.1016/j.jep.2019.112040 |
| 16 |
Liu F, Shen F, Bai Y, et al. Mechanism of DaiTongXiao in the treatment of gouty arthritis through the NLRP3 signaling pathway[J]. J Ethnopharmacol, 2024, 319, 117313.
doi: 10.1016/j.jep.2023.117313 |
| 17 |
Kobayashi EH, Suzuki T, Funayama R, et al. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription[J]. Nat Commun, 2016, 7 (1): 11624.
doi: 10.1038/ncomms11624 |
| 18 |
Lin G, Yu Q, Xu L, et al. Berberrubine attenuates potassium oxonate-and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway[J]. Eur J Pharmacol, 2021, 912, 174592.
doi: 10.1016/j.ejphar.2021.174592 |
| 19 |
Wu M, Tian Y, Wang Q, et al. Gout: a disease involved with complicated immunoinflammatory responses: a narrative review[J]. Clin Rheumatol, 2020, 39 (10): 2849- 2859.
doi: 10.1007/s10067-020-05090-8 |
| 20 |
Lin Y, Luo T, Weng A, et al. Gallic acid alleviates gouty arthritis by inhibiting NLRP3 inflammasome activation and pyroptosis through enhancing Nrf2 signaling[J]. Front Immunol, 2020, 11, 580593.
doi: 10.3389/fimmu.2020.580593 |
| 21 |
Luo L, Wang F, Xu X, et al. STAT3 promotes NLRP3 inflammasome activation by mediating NLRP3 mitochondrial translocation[J]. Exp Mol Med, 2024, 56 (9): 1980- 1990.
doi: 10.1038/s12276-024-01298-9 |
| 22 |
Reber LL, Marichal T, Sokolove J, et al. Contribution of mast cell-derived interleukin‐1β to uric acid crystal-induced acute arthritis in mice[J]. Arthritis Rheumatol, 2014, 66 (10): 2881- 2891.
doi: 10.1002/art.38747 |
| 23 |
Lv Y, Qi J, Babon JJ, et al. The JAK-STAT pathway: from structural biology to cytokine engineering[J]. Signal Transduct Target Ther, 2024, 9 (1): 221.
doi: 10.1038/s41392-024-01934-w |
| 24 |
Jiang Z, Yin X, Wang M, et al. β-Hydroxybutyrate alleviates pyroptosis in MPP+/MPTP-induced Parkinson’s disease models via inhibiting STAT3/NLRP3/GSDMD pathway[J]. Int Immunopharmacol, 2022, 113, 109451.
doi: 10.1016/j.intimp.2022.109451 |
| 25 |
Mariotte A, De Cauwer A, Po C, et al. A mouse model of MSU-induced acute inflammation in vivo suggests imiquimod-dependent targeting of Il-1β as relevant therapy for gout patients[J]. Theranostics, 2020, 10 (5): 2158.
doi: 10.7150/thno.40650 |
| 26 |
Martinon F, Pétrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome[J]. Nature, 2006, 440 (7081): 237- 241.
doi: 10.1038/nature04516 |
| 27 |
Xu X, Yu D, Wang Y, et al. Investigating the mechanisms of resveratrol in the treatment of gouty arthritis through the integration of network pharmacology and metabolics[J]. Front Endocrinol, 2024, 15, 1438405.
doi: 10.3389/fendo.2024.1438405 |
| 28 |
Hao K, Jiang W, Zhou M, et al. Targeting BRD4 prevents acute gouty arthritis by regulating pyroptosis[J]. Int J Biol Sci, 2020, 16 (16): 3163.
doi: 10.7150/ijbs.46153 |
| [1] | Zishuai WEN, Shengnan LIANG, Yuling RUAN, Wentao ZHANG, Mengying LI, Fangfang WU, Junhui LIU, Huazhen QIN. Exploring the mechanism of Alpiniae Officinarum Rhizoma and two other Alpinia Roxb medicinal materials in treating gastric ulcer with cold syndrome based on network pharmacology, molecular docking and experimental validation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(1): 28-39. |
| [2] |
LI Qian, WANG Zhenxiang, LIANG Yanting, MA Weiwei, ZHANG Zhen, WANG Xia, AN Qiong.
Effect and mechanism of Tamarix chinensis Lour. on streptozotocin-induced diabetic rats based on network pharmacology, molecular docking and experimental validation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(7): 907-920.
|
| [3] | GUO Ling, PENG Xiaoyong, DENG Mengsheng, ZHU Yingguo, WENG Changmei, CHENG Xiangyun, WANG Jianmin, LI Tao, LIU Liangming, YANG Guangming. Protective effects of transient receptor potential vanilloid 1 agonist capsaicin on traumatic hemorrhagic shock rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(6): 721-731. |
| [4] | YANG Weidong, WANG Ruiqi, WANG Haihua, YE Tianxiang, CHENG Shenghui, LI Huifang, HAO Xuliang. Flavonoid extract from Dracocephalum rupestre hance in improving gouty arthritis: study based on network pharmacology, molecular docking and animal experiment [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(6): 763-773. |
| [5] | LI Mingqi, WANG Yinghe, ZHAO Xiaolu, BAO Xiaomei, YUE Xin, REN Guiqiang, MA Yuehong. Mechanism of total flavonoids of Carthamus tinctorius L.against hepatic fibrosis based on LC-MS/MS combined with network pharmacology and pharmacology experiments [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(5): 586-598. |
| [6] | LIU Gen, YANG Weidong, LI Jia, LIU Cong, HAO Xuliang. Exploring the mechanism of action of BLJZF in the treatment of lipid abnormalities [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(4): 464-476. |
| [7] | ZHANG Huihui, JIN Le, LIU Su, CHEN Hongxiao, CHEN Zhaolin, TANG Liqin. Network pharmacological analysis of berberine inhibiting breast cancer cell proliferation and in vitro cell validation#br# [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(3): 332-338. |
| [8] |
FU Xiaoyan, GONG Zihan, GAO Guangmiao, YANG Biqian, DENG Yi, WANG Liping, YANG Xiujuan, YANG Zhijun.
Exploring the mechanism of Licorice in the treatment of liver injury induced by Semen Strychni based on network pharmacology, molecular docking and animal experiments
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(10): 1326-1341.
|
| [9] | LEI Chengjing, YU Miao, LI Yange, TANG Xiaoguang, ZHAO Fanrong, ZHU Tiantian. Exploring the mechanism of Xin Mai Jia in inhibiting hypertensive cardiac hypertrophy based on network pharmacology and animal experiments [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(1): 32-41. |
| [10] | Celimuge, Hudeligen, XU Liang. Network pharmacology-molecular docking analysis and experimental validation to explore the protective mechanism of Mongolian medicine Gaoyou on renal function [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(9): 968-978. |
| [11] | SU Qihui, WANG Jing, LUO Rongrong, HUANG Yurong, LI Xin, WANG Yingli, JIA Ying. Study on the mechanism of action of Siheifang on zebrafish melanin based on metabolomics and network pharmacology [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(9): 988-1001. |
| [12] | WANG Dan, ZHANG Wenyan, LUO Renjie, CHEN Yuanjing, HAN Xue, QU Bo, FENG Shifang, NIE Xiazi, LIU Huiling. Research progress of molecular docking in screening anti-cervical cancer drugs [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(8): 955-960. |
| [13] | LI Wen, JIANG Hugang, WANG Xinqiang, LI Yingdong, LIU Kai, ZHAO Xinke. Exploring the mechanism of Radix Angelica sinensis and Astragalus mongholicus extract therapy for radiationinduced myocardial fibrosis based on network pharmacology and experimental validation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(6): 601-611. |
| [14] | SU Xin, LUO Lin. UPLC-QE-MS combined network pharmacological analysis of the mechanism of ulcerative colitis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(3): 241-251. |
| [15] | ZHANG Tao, WANG Ruowei, FU Jialin, GAO Yue, HU Mingyuan, FANG Zhengmei, CHEN Yan, YAO Yingshui. Exploring the effect and mechanism of α-Linolenic acid on neuroinflammation based on network pharmacology and in vitro experiments [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(10): 1110-1119. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||